Recursion Pharmaceuticals Inc (RXRX)
8.20
+0.08
(+0.99%)
USD |
NASDAQ |
Apr 29, 16:00
8.02
-0.18
(-2.20%)
Pre-Market: 09:24
Recursion Pharmaceuticals Gross Profit Margin (Quarterly): 6.99% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.99% |
| September 30, 2023 | -7.67% |
| June 30, 2023 | 14.83% |
| March 31, 2023 | -2.59% |
| Date | Value |
|---|---|
| December 31, 2022 | 20.74% |
| September 30, 2022 | -18.05% |
| June 30, 2022 | -85.90% |
| March 31, 2022 | -47.18% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-85.90%
Minimum
Jun 2022
20.74%
Maximum
Dec 2022
-14.85%
Average
-5.13%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 80.88% |
| Palatin Technologies Inc | 95.20% |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Marinus Pharmaceuticals Inc | 87.66% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -71.74% |
| Return on Assets | -50.01% |
| Return on Invested Capital | -71.52% |
| Profit Margin (Quarterly) | -875.3% |
| Operating Margin (Quarterly) | -931.2% |
| Return on Net Operating Assets | -179.5% |